Literature DB >> 1281874

Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study.

S Wakui1, M Furusato, T Itoh, H Sasaki, A Akiyama, I Kinoshita, K Asano, T Tokuda, S Aizawa, S Ushigome.   

Abstract

One hundred and one cases of clinical prostatic carcinoma (PCa), primary site, were analysed to define the interrelationship between tumour angiogenesis, histological grade, and bone marrow metastasis. Tumour angiogenesis was determined by the blood capillary density ratio (BCDR; a/b), defined as the ratio between the area of the blood capillaries (a) and the area of the tumour (b). The BCDR was evaluated by a colour image analysis system employing a computerized morphometrical method. A total of 43 cases of PCa with bone marrow metastasis (stage D2) and 58 cases of PCa without metastasis (stage B, C) were utilized. The prostatic carcinomas were classified into three groups (low, intermediate, and high) using Gleason's grading system. The BCDR of the primary PCa with bone marrow metastasis was similar in each of the three histologically graded scores. On the other hand, in the cases of PCa without metastasis, the BCDR of high score PCa was higher than those of the low and intermediate score PCa (U-test; P < 0.001). The BCDR of the high score PCa without metastasis was similar to that of the PCa with bone marrow metastasis. The BCDR may provide help in predicting tumour progression with regard to bone marrow metastasis of PCa with low and intermediate Gleason's scores.

Entities:  

Mesh:

Year:  1992        PMID: 1281874     DOI: 10.1002/path.1711680303

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  41 in total

1.  Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.

Authors:  J A Beliën; S Somi; J S de Jong; P J van Diest; J P Baak
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

Review 2.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Zenya Naito
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

3.  Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer.

Authors:  Liwei Wang; Xiaohong Guan; Weida Gong; James Yao; Zhihai Peng; Daoyan Wei; Tsung-Teh Wu; Suyun Huang; Keping Xie
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  Intratumor microvessel density as a prognostic factor in cancer.

Authors:  N Weidner
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 5.  Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Authors:  J T Isaacs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma.

Authors:  M Cetinkaya; S Günçe; E Ulusoy; F Aksoy; O Yildiz; O Adsan; C Ozden
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 7.  Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

Authors:  Yoko Matsuda; Masahito Hagio; Toshiyuki Ishiwata
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Tumor angiogenesis in advanced stage ovarian carcinoma.

Authors:  H C Hollingsworth; E C Kohn; S M Steinberg; M L Rothenberg; M J Merino
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 10.  Intra-tumoural microvessel density in human solid tumours.

Authors:  J Hasan; R Byers; G C Jayson
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.